FDA Inspection
Novo Nordisk A/SNovo Nordisk A/S – FDA Inspection, Mar 20, 2012
Record Details
This FDA Inspection record concerns Novo Nordisk A/S, with an inspection on March 20, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Novo Nordisk A/S
- Inspection Date
- March 20, 2012
- Product Type
- Drugs
View Company Profile
ID · 0b479073-dd1d-404d-bc3a-9c85aa0dfabc
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 779822
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novo Nordisk A/S
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 29, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 8, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk A/S
- FDA Inspection 1245306 - 2023-03-29
- FDA Inspection 1165895 - 2019-12-05
- FDA Inspection 1057438 - 2018-05-18
- FDA Inspection 1007260 - 2017-02-08
- FDA Inspection 964462 - 2016-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.